1. Future Medical Treatment of PSC
    Elisabeth Krones et al, 2019, Current Hepatology Reports CrossRef
  2. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models
    Masakazu Yashiro et al, 2018, Human Cell CrossRef
  3. Identification and characterization of the promoter of cancer-related gene LOXL2
    Xin Liu et al, 2020, Experimental Cell Research CrossRef
  4. Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer
    Laura Pascual‐Reguant et al, 2023, EMBO Molecular Medicine CrossRef
  5. Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness
    Rongkun Li et al, 2021, Cell Death & Disease CrossRef
  6. Serum LOXL2 is Elevated and an Independent Biomarker in Patients with Coronary Artery Disease
    Zhongsheng Zhu, 2024, International Journal of General Medicine CrossRef
  7. Pan-Cancer Analysis of the LOX Family Reveals that LOX Affects Tumor Prognosis by Affecting Immune Infiltration
    Chunlong Zheng et al, 2024, Critical Reviews in Eukaryotic Gene Expression CrossRef
  8. Comparing transcriptomic profiles from seven cell lines to elucidate liver metastatic potential
    Lindsay R. Dresang et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
  9. Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation
    Yingming Zhao et al, 2017, Bioscience Reports CrossRef
  10. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
    Jiwoon Choi et al, 2019, Gut and Liver CrossRef
  11. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
    Utpreksha Vaish et al, 2021, International Journal of Molecular Sciences CrossRef
  12. Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis
    Giulia Fregni et al, 2018, EBioMedicine CrossRef
  13. MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
    Volker Ast et al, 2018, Oncotarget CrossRef
  14. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway
    Yingbiao Wu et al, 2022, Cerebrovascular Diseases CrossRef
  15. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment
    Elizabeth V. Nguyen et al, 2019, Molecular & Cellular Proteomics CrossRef
  16. Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma
    Keiichi Koshizuka et al, 2018, Oncotarget CrossRef
  17. Loss of phosphatase and tensin homolog (PTEN) increases Lysyl oxidase-like 2 (LOXL2) expression enhancing the growth of fallopian tube epithelial cells as three-dimensional spheroids
    Angela Russo et al, 2024, Cancer Pathogenesis and Therapy CrossRef
  18. Microarray expression profile of mRNAs and long noncoding RNAs and the potential role of PFK-1 in infantile hemangioma
    Kaiying Yang et al, 2021, Cell Division CrossRef
  19. Targeting cancer metastasis with antibody therapeutics
    Huilin Yang et al, 2021, WIREs Nanomedicine and Nanobiotechnology CrossRef
  20. Linking LOXL2 to Cardiac Interstitial Fibrosis
    Melisse Erasmus et al, 2020, International Journal of Molecular Sciences CrossRef
  21. Scutellaria barbata D. Don inhibits cervical cancer cell proliferation, migration, and invasion via miR-195-5p/LOXL2 axis
    Shouyu Xue et al, 2022, Toxicology Research CrossRef
  22. Extracellular Hsp90 Binds to and Aligns Collagen-1 to Enhance Breast Cancer Cell Invasiveness
    Pragya Singh et al, 2023, Cancers CrossRef
  23. Exosomes derived from ovarian cancer cells regulate proliferation and migration of cancer-associated fibroblasts
    Bo Ding et al, 2023, Genomics CrossRef
  24. A novel splice variant of LOXL2 promotes progression of human papillomavirus–negative head and neck squamous cell carcinoma
    Chao Liu et al, 2020, Cancer CrossRef
  25. Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity
    Kentaro Nishi et al, 2022, PLOS ONE CrossRef
  26. The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
    Sylvain D. Vallet et al, 2020, Cancers CrossRef
  27. Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB
    Faranak Mahjour et al, 2019, Oncogenesis CrossRef
  28. Tumor suppressor genes and allele-specific expression: mechanisms and significance
    Evan A. Clayton et al, 2020, Oncotarget CrossRef
  29. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
    Jianfeng Shu et al, 2023, Frontiers in Immunology CrossRef
  30. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma
    Lays M. Sobral et al, 2020, Molecular Oncology CrossRef
  31. Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance
    Ana Popovic et al, 2022, Frontiers in Oncology CrossRef
  32. KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma
    Lays Martin Sobral et al, 2020, Genes & Cancer CrossRef
  33. Comparative Transcriptomic Analysis of Regenerated Skins Provides Insights into Cutaneous Air-Breathing Formation in Fish
    Songqian Huang et al, 2021, Biology CrossRef
  34. Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
    Weichang Yang et al, 2023, Frontiers in Genetics CrossRef
  35. Tumor-Intrinsic Perinuclear LOXL2: Prognostic Relevance and Relationship with YAP1 Activation Status in Oral Squamous Cell Carcinoma
    Juan P. Rodrigo et al, 2024, Pathobiology CrossRef
  36. New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins
    Pilar Eraso et al, 2023, Molecules CrossRef
  37. Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma
    Keiichi Koshizuka et al, 2017, Cancer and Metastasis Reviews CrossRef
  38. Lysyl Oxidase: Its Diversity in Health and Diseases
    Suchitra Kumari et al, 2017, Indian Journal of Clinical Biochemistry CrossRef
  39. Transcriptome analyses of betta fish (Betta splendens) provide novel insights into fin regeneration and color-related genes
    Yunbang Zhang et al, 2023, Gene CrossRef
  40. Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging
    Reik Löser et al, 2023, ChemMedChem CrossRef
  41. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity
    Olga Almacellas-Rabaiget et al, 2020, Cancer Letters CrossRef
  42. The role of LOXL2 in tumor progression, immune response and cellular senescence: a comprehensive analysis
    Chen Ye et al, 2024, Discover Oncology CrossRef
  43. Exome Sequencing Identifies LOXL2 Mutation as a Cause of Familial Intracranial Aneurysm
    YaQiu Wu et al, 2018, World Neurosurgery CrossRef
  44. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
    Bing Shao et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
  45. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis
    Rongkun Li et al, 2019, Molecular Cancer CrossRef
  46. Lysyl Oxidase Like‐2 (LOXL2): An Emerging Oncology Target
    Vriddhi Chopra et al, 2020, Advanced Therapeutics CrossRef
  47. Influence of Silver Nanoparticles on the Growth of Ascitic and Solid Ehrlich Adenocarcinoma: Focus on Copper Metabolism
    Daria N. Magazenkova et al, 2023, Pharmaceutics CrossRef
  48. Abundant Expression of Lysyl Oxidase‐like 2 Protein in Intrahepatic Bile Ducts of Infants With Biliary Atresia
    Stefany Honigbaum et al, 2019, Journal of Pediatric Gastroenterology and Nutrition CrossRef
  49. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets
    Zodwa Dlamini et al, 2021, Genes CrossRef
  50. Quantitative Proteomics Implicates Rictor/mTORC2 in Cell Adhesion
    Hao Wang et al, 2018, Journal of Proteome Research CrossRef
  51. Novel Approaches for Extracellular Matrix Targeting in Disease Treatment
    Nikolaos A. Afratis et al, 2019, The Extracellular Matrix CrossRef
  52. Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses
    Jie Zhao et al, 2019, Scientific Reports CrossRef
  53. Is This the Last Requiem for Simtuzumab?
    Peter Fickert, 2019, Hepatology CrossRef
  54. Prognostic utility and clinical significance of lysyl oxidase‐like 2 protein expression in digestive system cancers
    Yi Zhang et al, 2019, Journal of Cellular Physiology CrossRef
  55. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice
    Dominic Cosgrove et al, 2018, Kidney International CrossRef
  56. Thorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse
    Andrea R. Lim et al, 2022, Seminars in Cancer Biology CrossRef
  57. The Role of eHsp90 in Extracellular Matrix Remodeling, Tumor Invasiveness, and Metastasis
    Pragya Singh et al, 2024, Cancers CrossRef
  58. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links
    Josephine Adams et al, 2019, Essays in Biochemistry CrossRef
  59. Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
    Suchitra Kumari et al, 2021, Diagnostics CrossRef
  60. Induction of altered gene expression profiles in cultured bovine granulosa cells at high cell density
    Anja Baufeld et al, 2017, Reproductive Biology and Endocrinology CrossRef
  61. LOXL2 reduces 5-FU sensitivity through the Hedgehog/BCL2 signaling pathway in colorectal cancer
    Zhize Qiu et al, 2023, Experimental Biology and Medicine CrossRef
  62. TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling
    Xin Zhang et al, 2023, Cellular Oncology CrossRef
  63. 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth
    Deborah A. Smithen et al, 2020, Journal of Medicinal Chemistry CrossRef
  64. Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification
    Chao Jiang et al, 2022, Frontiers in Molecular Biosciences CrossRef
  65. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity
    Kazushi Okada et al, 2018, Biochemistry CrossRef
  66. Molecular dynamics simulations on human fibulin-4 mutants D203A and E126K reveal conformational changes in EGF domains potentially responsible for enhanced protease lability and impaired extracellular matrix assembly
    Takako Sasaki et al, 2019, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef
  67. LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2
    Hua Yu et al, 2020, Cell Death & Differentiation CrossRef
  68. Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting
    Jelena Radić et al, 2023, International Journal of Molecular Sciences CrossRef
  69. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway
    Xi Hong et al, 2019, International Journal of Oncology CrossRef
  70. Exploring breast cancer treatment paradigms: innovative design, molecular docking and dynamic simulation of LOXL2 inhibitors
    Othman A. Baothman et al, 2024, Molecular Simulation CrossRef
  71. LOXL2 Inhibitors and Breast Cancer Progression
    Sandra Ferreira et al, 2021, Antioxidants CrossRef